Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.

Saved in:
Bibliographic Details
Title: Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.
Authors: Burger AVM; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands., Koot MA; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands., van Balen DEM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaeffers AWMA; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Zuur CL; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands., Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ridder M; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Hoetink AE; Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Center Utrecht, UMC Brain Centre, Utrecht, the Netherlands., Schutte T; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands., Crul M; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands. Electronic address: m.crul@amsterdamumc.nl.
Source: Oral oncology [Oral Oncol] 2025 May; Vol. 164, pp. 107246. Date of Electronic Publication: 2025 Apr 14.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40233546
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burger+AVM%22">Burger AVM</searchLink>; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Koot+MA%22">Koot MA</searchLink>; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Balen+DEM%22">van Balen DEM</searchLink>; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schaeffers+AWMA%22">Schaeffers AWMA</searchLink>; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zuur+CL%22">Zuur CL</searchLink>; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Devriese+LA%22">Devriese LA</searchLink>; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ridder+M%22">Ridder M</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoetink+AE%22">Hoetink AE</searchLink>; Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Center Utrecht, UMC Brain Centre, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schutte+T%22">Schutte T</searchLink>; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Crul+M%22">Crul M</searchLink>; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands. Electronic address: m.crul@amsterdamumc.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229709118%22">Oral oncology</searchLink> [Oral Oncol] 2025 May; Vol. 164, pp. 107246. <i>Date of Electronic Publication: </i>2025 Apr 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9709118 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0593 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213688375%22">13688375 </searchLink><i>NLM ISO Abbreviation: </i>Oral Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40233546
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.oraloncology.2025.107246
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 107246
    Titles:
      – TitleFull: Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burger AVM
      – PersonEntity:
          Name:
            NameFull: Koot MA
      – PersonEntity:
          Name:
            NameFull: van Balen DEM
      – PersonEntity:
          Name:
            NameFull: Schaeffers AWMA
      – PersonEntity:
          Name:
            NameFull: Zuur CL
      – PersonEntity:
          Name:
            NameFull: Devriese LA
      – PersonEntity:
          Name:
            NameFull: Ridder M
      – PersonEntity:
          Name:
            NameFull: Hoetink AE
      – PersonEntity:
          Name:
            NameFull: Schutte T
      – PersonEntity:
          Name:
            NameFull: Crul M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0593
          Numbering:
            – Type: volume
              Value: 164
          Titles:
            – TitleFull: Oral oncology
              Type: main
ResultId 1